Home » Stocks » LMAT

LeMaitre Vascular, Inc. (LMAT)

Stock Price: $62.92 USD 1.31 (2.13%)
Updated Jun 21, 2021 1:10 PM EDT - Market open
Market Cap 1.27B
Revenue (ttm) 134.70M
Net Income (ttm) 23.98M
Shares Out 20.55M
EPS (ttm) 1.16
PE Ratio 54.24
Forward PE 48.08
Dividend $0.40
Dividend Yield 0.63%
Trading Day June 21
Last Price $62.92
Previous Close $61.61
Change ($) 1.31
Change (%) 2.13%
Day's Open 62.19
Day's Range 61.77 - 63.64
Day's Volume 93,655
52-Week Range 23.57 - 63.64

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Hea...

1 week ago - GlobeNewsWire

BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical De...

3 weeks ago - GlobeNewsWire

BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Co...

1 month ago - GlobeNewsWire

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

1 month ago - Zacks Investment Research

LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and 0.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past year to $0.28, which bea...

1 month ago - Benzinga

BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarterly...

1 month ago - GlobeNewsWire

BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.

1 month ago - GlobeNewsWire

Bull Of The Day: LeMatire Vascular (LMAT)

1 month ago - Zacks Investment Research

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021, aft...

2 months ago - GlobeNewsWire

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, HRC, MASI, RMD
2 months ago - Zacks Investment Research

New Strong Buy Stocks for April 8th

Other stocks mentioned: CSTR, MDC, MYRG, NTR
2 months ago - Zacks Investment Research

BURLINGTON, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 20th Annual Needham Virtual H...

2 months ago - GlobeNewsWire

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: ABT, CSII, HOLX, HRC, IDXX, LH
2 months ago - Zacks Investment Research

Bridget Ross brings extensive experience in MedTech development and services; Joins advisory board of healthcare, logistics, capital markets and innovation leaders VANCOUVER, BC, March 23, 2021 /PRNewsw...

2 months ago - PRNewsWire

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

2 months ago - Zacks Investment Research

LeMaitre (LMAT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

3 months ago - Zacks Investment Research

Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 47.83% over the past year to $0.34, whic...

3 months ago - Benzinga

BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterly ...

3 months ago - GlobeNewsWire

BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences.

4 months ago - GlobeNewsWire

BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, ...

4 months ago - GlobeNewsWire

BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.

5 months ago - GlobeNewsWire

The LeMaitre's corporate health partly depends on how much its sales reps can do to overcome current blocks, and how soon the pandemic ends.

6 months ago - Seeking Alpha

LeMaitre has posted a strong quarter compounded by successful acquisition activity YTD, with little OPEX tied into profits in Q3. Management has widened the capital structure to be more debt inclusive, ...

6 months ago - Seeking Alpha

Here are five top-ranked liquid stocks, Winnebago Industries, (WGO), Shutterstock (SSTK), Logitech (LOGI), Ituran Location and Control (ITRN), and LeMaitre Vascular (LMAT), that investors can snap up fo...

Other stocks mentioned: ITRN, LOGI, SSTK, WGO
6 months ago - Zacks Investment Research

Here are four top-ranked liquid stocks, Winnebago Industries (WGO), Shutterstock (SSTK), Logitech (LOGI), and LeMaitre Vascular (LMAT), that investors can snap up for a winning portfolio.

Other stocks mentioned: LOGI, SSTK, WGO
6 months ago - Zacks Investment Research

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

7 months ago - Zacks Investment Research

Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S. Small Company Growth Composite Portfolio r...

7 months ago - Insider Monkey

BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference o...

7 months ago - GlobeNewsWire

BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November.

7 months ago - GlobeNewsWire

LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

LeMaitre (LMAT) delivered earnings and revenue surprises of 76.19% and 13.11%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Shares of LeMaitre Vascular (NASDAQ:LMAT) moved higher by 7.5% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 48.00% year over year to $0.3...

7 months ago - Benzinga

BURLINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2020 results and announced a $0.095/s...

7 months ago - GlobeNewsWire

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

BURLINGTON, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, af...

8 months ago - GlobeNewsWire

To increase the likelihood of unearthing high-quality companies, Benjamin Graham, the pioneer of value investing, recommended screening the market for stocks with a current ratio of more than 2 and high...

Other stocks mentioned: LPX, SWBI
9 months ago - GuruFocus

To increase the likelihood of unearthing high-quality companies, Benjamin Graham, the pioneer of value investing, recommended screening the market for stocks with a current ratio of more than 2 and high...

Other stocks mentioned: LPX, SWBI
9 months ago - GuruFocus

LeMaitre Vascular is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

9 months ago - Zacks Investment Research

LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

LeMaitre (LMAT) delivered earnings and revenue surprises of 440.00% and 59.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095...

10 months ago - GlobeNewsWire

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, af...

11 months ago - GlobeNewsWire

BURLINGTON, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5...

11 months ago - GlobeNewsWire

MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.

Other stocks mentioned: MDT, FMS, MSA
1 year ago - The Motley Fool

An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.

Other stocks mentioned: MGNX, QDEL, ZYXI
1 year ago - Zacks Investment Research

LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

About LMAT

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Oct 19, 2006
CEO
George LeMaitre
Employees
386
Stock Exchange
NASDAQ
Ticker Symbol
LMAT
Full Company Profile

Financial Performance

In 2020, LMAT's revenue was $129.37 million, an increase of 10.35% compared to the previous year's $117.23 million. Earnings were $21.22 million, an increase of 18.32%.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 59.80, which is a decrease of -4.96% from the latest price.

Price Target
$59.80
(-4.96% downside)
Analyst Consensus: Buy